scale cause noticeable symptoms trouble learning golomb theory supported 2006 study published geneticist georgirene vladutiu university buffalo vladutiu reported statin users experience muscle pain weakness effect likely users preexisting genetic defects related cellular energy production brain cells muscle cells high energy users interestingly studies suggest statins improve memory certain people lowering risk dementia benefit occur cholesterol involved production protein clusters hallmark neurodegenerative diseases alzheimer parkinson statins neurologically protective problematic given opposing effects probably arise different biochemical pathways statins differ formulations affect processes users different genetic predispositions simply switching drugs help people experiencing warning signs forgetting names 2009 study published golomb